Sarah Jeanne Schrauben, MD, MSCE

faculty photo
Assistant Professor of Medicine (Renal-Electrolyte and Hypertension) at the Hospital of the University of Pennsylvania
Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania
Senior Scholar, Clinical Center for Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania
Faculty Affiliate, Center for Health Incentives and Behavioral Economics, University of Pennsylvania
Research Associate, Population Aging Research Center, University of Pennsylvania
Department: Medicine

Contact information
Renal Division, 1 Founders
3400 Spruce St
Philadelphia, PA 19103
BS (Human Biology)
Michigan State University, 2007.
MD (Medicine)
Michigan State University College of Human Medicine, 2011.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2017.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Chronic Kidney Disease, Hypertension, Shared-decision making

Description of Research Expertise

Sarah Schrauben, MD, MSCE is Assistant Professor of Medicine and Epidemiology in the Division of Renal, Electrolyte, and Hypertension, and Department of Biostatistics, Epidemiology, and Informatics at the Perelman School of Medicine and a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania. Her research focuses on the impact of health behaviors and modifiable risk factors in the development and management of chronic kidney disease (CKD) and its complications, as well as addressing implementation gaps of evidence-based care in CKD. She has contributed to the growing evidence base that seeks to prioritize behavior recommendations for management of CKD as well as assessing barriers to healthy behavior engagement. She has conducted studies that have identified high levels of substandard health behavior engagement among adults with CKD and phenotypes of behavior engagement that associate with clinical outcomes in this population. Her work also has assessed for real-time barriers to health behaviors by interviewing patients with CKD and developing a patient-centered behavioral intervention that leverages mobile health technology to increase engagement in healthy behaviors. She is currently conducting feasibility testing of the intervention in a clinical trial. Dr. Schrauben’s research aims to address implementation gaps in evidence-based CKD care. She is currently expanding her investigations in disease management by exploring the impact of functional status among those with CKD and multi-morbidity. Her future work aims to guide the development of innovative strategies to improve clinical and patient-reported outcomes in CKD.

Selected Publications

Vasquez Rios G, Katz R, Cushman M, Parikh C, Kimmel P, Waikar SS, Schrauben SJ, Greenberg J, Sarnak M, Shlipak MG, Ix JH, Guierrez OM: Urinary biomarkers and mortality in individuals with chronic kidney disease and diabetes mellitus. Kidney360 October, online ahead of print 2023.

Schrauben SJ, O'Brien CS, Bilger A: Investigating Barriers to Implementation of Functional Status Assessments in CKD Care: A Mixed Methods Study Among Stakeholders. Journal of American Society of Nephrology October 2023.

Schrauben SJ, Purcell A, Bilger A, Amaral S, Feldman HI, Dember LM: Supporting Self-Management of Healthy Behaviors (SMART-HABITS) in CKD and Hypertension: A Pilot Trial. Journal of American Society of Nephrology October 2023.

Jian K, Greenberg JH, Abraham A, Xu Y, Schelling JR, Feldman HI, Schrauben SJ, Waikar SS, Shlipak MG, Wettersten N, Coca S, Ramachandran SV, Gutierrez OM, Ix JH, Warady B, Kimmel P, Bonventre JV, Parikh CR, Mitsnefes M, Denburg M, Furth S: Associations of Biomarkers of Kidney Tubule Health, Injury, and Inflammation with Left Ventricular Hypertrophy in Children with CKD. Kidney360 June, online ahead of print 2023.

Babroudi S, Tighiouart H, Schrauben SJ, Cohen J, He J, Rao P, Fischer MJ, Rahman M, Go AS, Hsu C-Y, Sozio SM, Weir M, Sarnak M, Yaffe K, Tamura MK, Drew D: Baseline and Time-Updated Blood Pressure and Cognitive Impairment in the Chronic Renal Insufficiency Cohort. American Journal of Kidney Diseases May; Online ahead of print 2023.

Sullivan VK, Appel LJ, Anderson CAM, Tan TC, Brown J, Ricardo AC, Schrauben SJ, Hsu C-Y, Shah VO, Unruh M, Nelson RG, Sondheimer J, Chen J, He J, Charleston J, Rebholz CM: Changes in Dietary Quality, Risk of Chronic Kidney Disease Progression and All-Cause Mortality in the CRIC Study. American Journal of Kidney Diseases 81(5): 621-624, May 2023.

Schrauben SJ, Sapa H, Anderson AH, Hsu C-Y, Ix JH, Shafi T, Shlipak MG, Chen J, Hostetter TH, Brown J, Mehta R, Townsend RR, Seegmiller JC, Kimmel PL, Ramachandran VS, Feldman HI, Schelling JR: Association of urine and plasma ADMA with atherosclerotic cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Nephrology, Dialysis and Transplant May, online ahead of print 2023.

Wettersten N, Katz R, Greenberg JH, Gutierrez OM, Lima JAC, Sarnak MJ, Schrauben SJ, Deo R, Bonventre J, Ramachandran V, Kimmel P, Shlipak M, Ix JH. : Association of Kidney Tubule Biomarkers with Cardiac Structure and Function: The Multi-Ethnic Study of Atherosclerosis. American Journal of Cardiology 196: 11-18, April 2023.

Schrauben SJ, Becker, WC. : Balancing Risk and Uncertain Benefit in Pharmacotherapy for Pain in Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology 18(1): 3-4, January 2023.

Schrauben SJ, Anderson AH, Hsu C-Y, Ix JH, Shafi T, Shlipak MG, Chen J, Hostetter TH, Brown J, Mehta R, Townsend RR, Seegmiller JC, Kimmel PL, Ramachandran VS, Feldman HI, Schelling JR: Higher Plasma ADMA Levels and Lower ADMA and SDMA Fractional Excretion Were Associated with Risk of Atherosclerotic Cardiovascular Disease in Diabetic Kidney Disease. J Am Soc Nephrol 33(suppl 1): S115, October 2022.

back to top
Last updated: 09/18/2023
The Trustees of the University of Pennsylvania